JP MORGAN/PUT/ABBOTT LABORATORIES/105/0.1/15.11.24 Stock

Warrant

DE000JK4CPA2

Market Closed - Börse Stuttgart 04:58:23 2024-07-05 EDT
0.61 EUR +3.39% Intraday chart for JP MORGAN/PUT/ABBOTT LABORATORIES/105/0.1/15.11.24
Current month+24.49%
1 month+15.09%
Date Price Change
24-07-05 0.61 +3.39%
24-07-04 0.59 +9.26%
24-07-03 0.54 -3.57%
24-07-02 0.56 +9.80%
24-07-01 0.51 +4.08%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 04:58 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK4CPA
ISINDE000JK4CPA2
Date issued 2024-03-19
Strike 105 $
Maturity 2024-11-15 (131 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.7
Lowest since issue 0.37
Spread 0.01
Spread %1.85%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
124.9 USD
Spread / Average Target
+20.09%
Consensus